Andra AP fonden decreased its position in shares of Aflac Incorporated (NYSE:AFL – Free Report) by 9.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 78,700 shares of the financial services provider’s stock after selling 8,100 shares during the quarter. Andra AP fonden’s holdings in Aflac were worth $8,141,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in AFL. Pettinga Financial Advisors LLC bought a new stake in shares of Aflac in the 3rd quarter worth $203,000. Principal Financial Group Inc. boosted its position in shares of Aflac by 0.5% during the third quarter. Principal Financial Group Inc. now owns 643,686 shares of the financial services provider’s stock valued at $71,964,000 after buying an additional 3,244 shares during the last quarter. Kornitzer Capital Management Inc. KS bought a new stake in Aflac in the 3rd quarter worth about $246,000. AEGON ASSET MANAGEMENT UK Plc raised its position in Aflac by 0.9% in the 3rd quarter. AEGON ASSET MANAGEMENT UK Plc now owns 222,962 shares of the financial services provider’s stock worth $24,925,000 after buying an additional 1,941 shares during the last quarter. Finally, CWA Asset Management Group LLC purchased a new position in Aflac in the 3rd quarter worth about $810,000. Institutional investors own 67.44% of the company’s stock.
Analysts Set New Price Targets
A number of analysts have recently commented on the stock. Keefe, Bruyette & Woods reduced their price target on shares of Aflac from $107.00 to $104.00 and set a “market perform” rating for the company in a research note on Wednesday, February 12th. Barclays cut their target price on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating for the company in a research report on Friday, February 7th. JPMorgan Chase & Co. increased their price target on Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a report on Tuesday, January 7th. Piper Sandler cut their price objective on Aflac from $122.00 to $118.00 and set an “overweight” rating for the company in a report on Friday, February 7th. Finally, BMO Capital Markets began coverage on Aflac in a research report on Thursday, January 23rd. They set a “market perform” rating and a $111.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $103.36.
Insider Buying and Selling at Aflac
In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total transaction of $2,558,529.60. Following the completion of the sale, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This trade represents a 10.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.90% of the company’s stock.
Aflac Price Performance
NYSE AFL opened at $108.48 on Friday. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 12 month low of $79.31 and a 12 month high of $115.50. The stock has a market cap of $59.29 billion, a price-to-earnings ratio of 11.30, a PEG ratio of 3.24 and a beta of 0.93. The company’s 50 day moving average is $105.08 and its two-hundred day moving average is $107.72.
Aflac (NYSE:AFL – Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, research analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.
Aflac Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
Featured Articles
- Five stocks we like better than Aflac
- High Dividend REITs: Are They an Ideal Way to Diversify?
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- 3 Tickers Leading a Meme Stock Revival
- 3 Stocks to Buy While Others Stay on the Sidelines
- Do ETFs Pay Dividends? What You Need to Know
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.